|
GB1419788A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
Herbicidal method using 2-trifuluromethyl-4-quinolinols
|
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
|
ATE161530T1
(de)
|
1992-09-04 |
1998-01-15 |
Takeda Chemical Industries Ltd |
Kondensierte heterozyklische verbindungen, deren herstellung und verwendung
|
|
ATE239797T1
(de)
|
1993-01-25 |
2003-05-15 |
Takeda Chemical Industries Ltd |
Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
|
|
ES2194937T3
(es)
|
1995-03-24 |
2003-12-01 |
Takeda Chemical Industries Ltd |
Compuestos ciclicos, su produccion y uso como antagonistas de los receptores de taquiquinina.
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
DK0994728T3
(da)
|
1997-04-09 |
2008-12-01 |
Intellect Neurosciences Inc |
Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
AU2787299A
(en)
|
1998-03-03 |
1999-09-20 |
Ppg Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
CA2352612A1
(en)
|
1998-11-27 |
2000-06-08 |
Hideo Fukui |
Pharmaceuticals
|
|
CZ304211B6
(cs)
|
2000-02-24 |
2014-01-08 |
Washington University |
Humanizovaná protilátka, její fragment a jejich použití, polynukleová kyselina, expresní vektor, buňka a farmaceutický prostředek
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
JP4708675B2
(ja)
|
2000-11-03 |
2011-06-22 |
プロテオテック・インコーポレーテッド |
ウンカリア・トメントーサおよび関連植物からアミロイド阻害化合物を単離する方法ならびに単離した化合物の使用
|
|
EP1432444A4
(en)
|
2001-08-17 |
2005-11-02 |
Lilly Co Eli |
ANTI-BETA ANTIBODIES
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
|
BR0315157A
(pt)
|
2002-10-09 |
2005-08-09 |
Rinat Neuroscience Corp |
Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
|
|
CA2501799C
(en)
|
2002-10-09 |
2008-06-17 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
BRPI0410630A
(pt)
|
2003-06-19 |
2006-06-13 |
Pfizer Prod Inc |
antagonista de nk1
|
|
BRPI0413709A
(pt)
|
2003-08-21 |
2006-10-17 |
Pfizer Prod Inc |
compostos para o tratamento de distúrbios neurodegenerativos
|
|
CA2538220A1
(en)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
WO2005072361A2
(en)
|
2004-01-28 |
2005-08-11 |
Merck & Co., Inc. |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
|
JP2007519707A
(ja)
|
2004-02-02 |
2007-07-19 |
ファイザー・プロダクツ・インク |
ヒスタミン−３受容体モジュレーター
|
|
CA2557785A1
(en)
|
2004-03-09 |
2005-10-06 |
Merck & Co. Inc. |
Hiv integrase inhibitors
|
|
ATE399155T1
(de)
|
2004-03-23 |
2008-07-15 |
Pfizer Prod Inc |
Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
|
|
CA2562713A1
(en)
|
2004-04-14 |
2005-12-15 |
Gilead Sciences, Inc. |
Phosphonate analogs of hiv integrase inhibitor compounds
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
EP2298807A3
(en)
|
2004-07-30 |
2011-05-18 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20090074775A1
(en)
|
2004-12-22 |
2009-03-19 |
David Michael Holtzman |
Use Of Anti-AB Antibody To Treat Traumatic Brain Injury
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
AU2006244424B2
(en)
|
2005-05-10 |
2011-09-22 |
Merck Sharp & Dohme Corp. |
HIV integrase inhibitors
|
|
US8227475B2
(en)
|
2005-05-12 |
2012-07-24 |
Pfizer Inc. |
Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
|
WO2006126082A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
ATE488496T1
(de)
|
2005-06-22 |
2010-12-15 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
JP2009514846A
(ja)
|
2005-11-04 |
2009-04-09 |
ファイザー・リミテッド |
テトラヒドロナフチリジン誘導体
|
|
US20080275251A1
(en)
|
2005-11-18 |
2008-11-06 |
Glaxo Group Limited |
Novel Intermediates and Their Use
|
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
MY144960A
(en)
|
2005-11-24 |
2011-11-30 |
Eisai R&D Man Co Ltd |
Morpholine type cinnamide compound
|
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
WO2007084595A2
(en)
|
2006-01-20 |
2007-07-26 |
Schering Corporation |
Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
EP2007749A2
(en)
|
2006-03-13 |
2008-12-31 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
|
PL2013208T3
(pl)
|
2006-04-21 |
2011-10-31 |
Pfizer Prod Inc |
Pirydyno[3,4-B]pirazynowy
|
|
EP2021327B1
(en)
|
2006-05-15 |
2012-04-04 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
NZ572367A
(en)
|
2006-05-16 |
2011-09-30 |
Gilead Sciences Inc |
Fused cyclic compounds as integrase inhibitors
|
|
JPWO2007135969A1
(ja)
|
2006-05-19 |
2009-10-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ウレア系−シンナミド誘導体
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
SI2124933T1
(sl)
|
2007-01-22 |
2012-12-31 |
Pfizer Products Inc. |
Tosilatna sol terapevtske spojine in farmacevtski sestavi tega
|
|
US8252803B2
(en)
|
2007-02-12 |
2012-08-28 |
Merck Sharp & Dohme Corp. |
Piperidine derivatives
|
|
EP2121633A2
(en)
|
2007-02-12 |
2009-11-25 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
PE20081791A1
(es)
|
2007-02-28 |
2009-02-07 |
Eisai Randd Man Co Ltd |
Dos derivados ciclicos de oxomorfolina
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
EP2155737A1
(en)
|
2007-05-07 |
2010-02-24 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2009012163A
(es)
|
2007-05-11 |
2009-12-01 |
Hoffmann La Roche |
Hetarilanilinas como moduladores para beta-amiloide.
|
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
|
AU2008263207B2
(en)
|
2007-06-01 |
2013-10-03 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
EP2164852A2
(en)
|
2007-06-01 |
2010-03-24 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2166854A4
(en)
|
2007-06-13 |
2012-05-16 |
Merck Sharp & Dohme |
TRIAZONE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER AND RELATED SUFFERINGS
|
|
CL2008001914A1
(es)
|
2007-06-29 |
2009-07-17 |
Schering Corp |
Compuestos heterociclicos de nitrogeno y oxigeno,moduladores de gama secretasa, composicion farmaceutica de dichos compuestos; kit farmaceutico y su uso para prevenir o tratar enfermedades asociadas al sistema nervioso central como alzheimer, sindrome de down, enfermedades neurodegenerativas, inhibir el deposito de proteina amiloide.
|
|
MX2010001506A
(es)
|
2007-08-06 |
2010-03-10 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
MX2010002098A
(es)
|
2007-08-31 |
2010-03-30 |
Eisai R&D Man Co Ltd |
Compuesto policiclico.
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
CN101848897A
(zh)
|
2007-09-06 |
2010-09-29 |
先灵公司 |
γ分泌酶调节剂
|
|
MX2010003397A
(es)
|
2007-09-28 |
2010-04-09 |
Schering Corp |
Moduladores de la gamma secretasa.
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009061699A1
(en)
|
2007-11-05 |
2009-05-14 |
Schering Corporation |
Gamma secretase modulators
|
|
CN101939312A
(zh)
*
|
2007-12-06 |
2011-01-05 |
先灵公司 |
γ分泌酶调节剂
|
|
CA2708151A1
(en)
|
2007-12-11 |
2009-06-18 |
Schering Corporation |
Gamma secretase modulators
|
|
JP2011506461A
(ja)
|
2007-12-11 |
2011-03-03 |
シェーリング コーポレイション |
γ−セクレターゼモジュレーター
|
|
EP2231602A1
(en)
|
2007-12-13 |
2010-09-29 |
Amgen, Inc |
Gamma secretase modulators
|
|
EP2231629B1
(en)
|
2008-01-11 |
2011-11-30 |
F. Hoffmann-La Roche AG |
Modulators for amyloid beta
|
|
EP2257541B1
(en)
|
2008-02-22 |
2013-08-14 |
F. Hoffmann-La Roche AG |
Modulators for amyloid beta
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2257542A1
(en)
|
2008-02-29 |
2010-12-08 |
Schering Corporation |
Gamma secretase modulators for the treatment of alzheimer ' s disease
|
|
CA2722606A1
(en)
|
2008-05-05 |
2009-11-12 |
Amgen Inc. |
Urea compounds as gamma secretase modulators
|
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
|
WO2010019393A1
(en)
|
2008-08-13 |
2010-02-18 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives for treatment of alzheimer's disease
|
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
|
JP2012501336A
(ja)
|
2008-08-27 |
2012-01-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
シンナミド化合物の製造法
|
|
WO2010040661A1
(en)
|
2008-10-09 |
2010-04-15 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
WO2010054064A1
(en)
|
2008-11-06 |
2010-05-14 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2011004680A
(es)
|
2008-11-06 |
2011-05-25 |
Astrazeneca Ab |
Moduladores de beta amiloide.
|
|
AU2009313527A1
(en)
|
2008-11-06 |
2010-05-14 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
JP5378532B2
(ja)
|
2008-11-10 |
2013-12-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
複素環γ−セクレターゼモジュレーター
|
|
EP2379075A4
(en)
|
2008-12-16 |
2012-05-30 |
Merck Sharp & Dohme |
TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
|
|
US8575150B2
(en)
|
2008-12-16 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of Alzheimer's disease
|
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
|
JP2012512834A
(ja)
|
2008-12-19 |
2012-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
炎症、喘息及びｃｏｐｄの処置のためのｃｃｒ２受容体アンタゴニストとしての環状ピリミジン−４−カルボキサミド
|
|
US20120135980A1
(en)
|
2008-12-22 |
2012-05-31 |
Theodros Asberom |
Gamma secretase modulators
|
|
EP2379563B1
(en)
|
2008-12-22 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
|
NZ593951A
(en)
|
2009-02-06 |
2013-01-25 |
Ortho Mcneil Janssen Pharm |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
|
TWI461425B
(zh)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
|
BRPI1007883A2
(pt)
|
2009-02-26 |
2016-02-23 |
Eisai R&D Man Co Ltd |
sal, e, cristal.
|
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
|
EP2403835A1
(en)
|
2009-03-03 |
2012-01-11 |
Pfizer Inc. |
Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
|
|
JP5771207B2
(ja)
|
2009-08-07 |
2015-08-26 |
ダウ アグロサイエンシィズ エルエルシー |
有害生物防除組成物
|
|
JP2013508350A
(ja)
*
|
2009-10-20 |
2013-03-07 |
ファイザー・インク |
ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール
|
|
CN102762548B
(zh)
*
|
2009-12-22 |
2014-11-26 |
沃泰克斯药物股份有限公司 |
磷脂酰肌醇3-激酶的异吲哚啉酮抑制剂
|
|
ES2602794T3
(es)
*
|
2011-03-31 |
2017-02-22 |
Pfizer Inc |
Piridinonas bicíclicas novedosas
|
|
NZ702611A
(en)
*
|
2012-05-16 |
2016-10-28 |
Cellzome Ltd |
Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer’s disease
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
AU2013366668B2
(en)
|
2012-12-20 |
2017-07-20 |
Janssen Pharmaceutica Nv |
Novel tricyclic 3,4-dihydro-2H-pyrido[1,2-alpha]pyrazine -1,6-dione derivatives as gamma secretase modulators
|
|
US10246454B2
(en)
|
2013-01-17 |
2019-04-02 |
Janssen Pharmaceutica Nv |
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
|
|
EP3052495B1
(en)
|
2013-10-04 |
2019-06-26 |
Pfizer Inc |
Novel bicyclic pyridinones as gamma-secretase modulators
|
|
CN106413623B
(zh)
|
2014-03-21 |
2020-07-03 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
PE20161364A1
(es)
|
2014-04-01 |
2016-12-25 |
Pfizer |
CROMENO Y 1,1a,2,7b-TETRAHIDROCICLOPROPA [C] CROMENO PIRIDOPIRAZINADIONAS NOVEDOSAS
|